ARTIVION, INC.
AORTNYSEHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $441.3M | $388.5M | $354.0M | $313.8M | $298.8M | $253.2M |
| Operating income | $33.7M | $38.9M | $5.7M | $6.2M | $8.1M | $2.4M |
| Net income | $9.8M | −$13.4M | −$30.7M | −$19.2M | −$14.8M | −$16.7M |
| Total assets | $884.8M | $789.1M | $792.4M | $762.8M | $793.1M | $789.4M |
| Total liabilities | $436.6M | $512.9M | $510.6M | $478.5M | $492.3M | $460.7M |
| Equity | $448.2M | $276.2M | $281.8M | $284.3M | $300.7M | $328.7M |
| EPS (diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 |
| Shares out. | 42.0M | 41.2M | 40.6M | 40.1M | 39.0M | 39.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 7.6%
- Net margin
- 2.2%
- Return on equity
- 2.2%
- Return on assets
- 1.1%
- Return on capital (ROCE)
- 4.3%
- Liabilities / assets
- 49.3%
- Debt / equity
- 0.97×
- Book value / share
- $10.66
- Revenue growth (YoY)
- 13.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 3.05safe
- Accruals / assets
- −3.4%clean
- Beneish M-Score
- -2.44normal
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 26, 2026
- Nomura Asset Management International Inc.Passive (13G)Feb 17, 2026
- Macquarie Group LtdPassive (13G)Feb 13, 2026
- Perceptive Advisors LlcPassive (13G)Nov 14, 2025
- Morgan StanleyPassive (13G)Nov 7, 2025
- Blackrock, Inc.Passive (13G)Oct 17, 2025
- Juniper Investment Company, LlcActivist (13D)Aug 12, 2025
- Fmr LlcPassive (13G)Aug 6, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.9M | 1.7 | +1.1% |
| Apr 30, 2026 | 1.9M | 6.3 | -1.2% |
| Apr 15, 2026 | 1.9M | 3.7 | +16.6% |
| Mar 31, 2026 | 1.7M | 4.3 | -0.4% |
| Mar 13, 2026 | 1.7M | 4.2 | +6.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosure · Other material eventMay 18, 2026
- Shareholder voteMay 15, 2026
- Entered a material agreement · Results of operationsMay 7, 2026
- Results of operationsFeb 12, 2026
- Results of operationsNov 6, 2025
- Entered a material agreementSep 29, 2025
- Entered a material agreement · New financial obligationSep 15, 2025
- Director / officer changeAug 11, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.